Largos supervivientes y terapias dirigidas en melanoma avanzado - page 44

Trame + dabra + PDR001

(NCT02967692)

Fase seguridad

Fase

biomarcadores

Fase aleatorizada

N=440, 1ª L

Dabrafenib + Trametinib + PDR001

Dabrafenib + Trametinib + Placebo

Uso experimental, no autorizado

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,34,35,36,37,38,39,40,41,42,43 45,46